LISDEXAMFETAMINE DIMESYLATE

LISDEXAMFETAMINE DIMESYLATE was reported 33463 times

These side effects are most commonly reported by patients taking LISDEXAMFETAMINE DIMESYLATE:

# Side effect Count
0 DRUG INEFFECTIVE 4768
1 FATIGUE 2100
2 OFF LABEL USE 2063
3 ANXIETY 1851
4 HEADACHE 1805
5 NAUSEA 1597
6 PRODUCT AVAILABILITY ISSUE 1583
7 INSOMNIA 1505
8 DEPRESSION 1415
9 FEELING ABNORMAL 1368
10 PRODUCT USE ISSUE 1335
11 DISTURBANCE IN ATTENTION 1284
12 NO ADVERSE EVENT 1206
13 PRODUCT QUALITY ISSUE 1205
14 INTENTIONAL OVERDOSE 1155
15 INTENTIONAL SELF-INJURY 1109
16 SOMNOLENCE 1104
17 CONDITION AGGRAVATED 1085
18 DIZZINESS 1055
19 INABILITY TO AFFORD MEDICATION 1036
20 WEIGHT DECREASED 996
21 DECREASED APPETITE 963
22 PAIN 949
23 SUICIDAL IDEATION 900
24 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 825
25 IRRITABILITY 795
26 VOMITING 793
27 DRUG EFFECT DECREASED 766
28 INSURANCE ISSUE 738
29 PRODUCT DOSE OMISSION ISSUE 730
30 MALAISE 726
31 PRODUCT PHYSICAL ISSUE 706
32 RASH 679
33 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 669
34 WEIGHT INCREASED 665
35 AGGRESSION 650
36 PALPITATIONS 649
37 DYSPNOEA 641
38 DIARRHOEA 604
39 INCORRECT DOSE ADMINISTERED 577
40 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 553
41 ABDOMINAL PAIN UPPER 545
42 ASTHENIA 542
43 MIGRAINE 538
44 PRODUCT SUBSTITUTION ISSUE 535
45 AGITATION 525
46 ARTHRALGIA 525
47 HEART RATE INCREASED 519
48 ANGER 505
49 HYPERHIDROSIS 489
50 PYREXIA 479
51 TREMOR 476
52 PAIN IN EXTREMITY 473
53 ABDOMINAL DISCOMFORT 465
54 CONFUSIONAL STATE 462
55 ABNORMAL BEHAVIOUR 456
56 DEPRESSED MOOD 447
57 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 445
58 BLOOD PRESSURE INCREASED 444
59 STRESS 443
60 PRODUCT USE IN UNAPPROVED INDICATION 440
61 COVID-19 439
62 PRURITUS 435
63 DRY MOUTH 417
64 HYPOAESTHESIA 416
65 MEMORY IMPAIRMENT 413
66 UNEVALUABLE EVENT 407
67 DRUG DOSE OMISSION 398
68 INTENTIONAL PRODUCT USE ISSUE 396
69 FALL 389
70 HYPERTENSION 385
71 CRYING 384
72 PARAESTHESIA 368
73 THERAPEUTIC RESPONSE SHORTENED 365
74 MUSCLE SPASMS 364
75 OVERDOSE 363
76 TIC 362
77 CHEST PAIN 360
78 ABDOMINAL PAIN 357
79 SLEEP DISORDER 350
80 VISION BLURRED 344
81 COUGH 336
82 ADVERSE DRUG REACTION 333
83 NASOPHARYNGITIS 329
84 THERAPEUTIC RESPONSE UNEXPECTED 326
85 BACK PAIN 323
86 PRESCRIBED OVERDOSE 319
87 ILLNESS 318
88 CONSTIPATION 312
89 HYPERSENSITIVITY 308
90 PSYCHOMOTOR HYPERACTIVITY 307
91 DRUG INTERACTION 306
92 TACHYCARDIA 306
93 ALOPECIA 299
94 HALLUCINATION 299
95 WITHDRAWAL SYNDROME 295
96 INJECTION SITE PAIN 280
97 URTICARIA 277
98 DYSGEUSIA 276
99 LOSS OF CONSCIOUSNESS 274
100 EMOTIONAL DISORDER 270
101 MOOD SWINGS 265
102 SEIZURE 259
103 SINUSITIS 258
104 PANIC ATTACK 254
105 PSYCHOTIC DISORDER 254
106 ARTHRITIS 250
107 THERAPEUTIC PRODUCT EFFECT DECREASED 249
108 ERYTHEMA 247
109 FEELING JITTERY 245
110 MOOD ALTERED 244
111 IMPAIRED WORK ABILITY 242
112 MYALGIA 242
113 DRUG DEPENDENCE 238
114 SUICIDE ATTEMPT 237
115 NERVOUSNESS 236
116 THERAPY INTERRUPTED 236
117 MENTAL DISORDER 234
118 ADVERSE EVENT 226
119 NIGHTMARE 224
120 DRUG HYPERSENSITIVITY 223
121 SEDATION 222
122 HAEMATOCHEZIA 221
123 PARANOIA 220
124 MATERNAL EXPOSURE DURING PREGNANCY 219
125 VERTIGO 219
126 PNEUMONIA 217
127 VISUAL IMPAIRMENT 216
128 ECZEMA 215
129 SWOLLEN TONGUE 214
130 ACNE 213
131 OROPHARYNGEAL PAIN 213
132 CHEST DISCOMFORT 212
133 PRODUCT ADMINISTRATION INTERRUPTED 210
134 ASTHMA 202
135 COLITIS ULCERATIVE 201
136 DRUG INTOLERANCE 201
137 EMOTIONAL DISTRESS 201
138 TINNITUS 201
139 IMPAIRED QUALITY OF LIFE 198
140 LETHARGY 197
141 SYNCOPE 192
142 ACCIDENTAL OVERDOSE 189
143 BRAIN FOG 189
144 MEDICATION ERROR 187
145 GASTROINTESTINAL DISORDER 185
146 SURGERY 185
147 THERAPEUTIC RESPONSE DECREASED 185
148 CEREBROVASCULAR ACCIDENT 184
149 DRUG EFFECT LESS THAN EXPECTED 184
150 MANIA 184
151 APATHY 181
152 DRUG EFFECT INCREASED 181
153 FREQUENT BOWEL MOVEMENTS 180
154 RESTLESSNESS 179
155 ATTENTION DEFICIT HYPERACTIVITY DISORDER 175
156 IMPULSIVE BEHAVIOUR 175
157 PERIPHERAL SWELLING 175
158 INFLUENZA 174
159 INTENTIONAL PRODUCT MISUSE 174
160 DEHYDRATION 173
161 GAIT DISTURBANCE 171
162 TREATMENT FAILURE 168
163 SLEEP APNOEA SYNDROME 167
164 DYSKINESIA 165
165 FEELING HOT 164
166 PRE-EXISTING CONDITION IMPROVED 164
167 DISSOCIATION 161
168 DRUG ABUSE 161
169 TOXICITY TO VARIOUS AGENTS 160
170 DYSPEPSIA 156
171 URINARY TRACT INFECTION 156
172 DRUG WITHDRAWAL SYNDROME 155
173 HUNGER 155
174 THERAPEUTIC PRODUCT EFFECT VARIABLE 155
175 CONTUSION 154
176 MUSCULOSKELETAL STIFFNESS 154
177 BIPOLAR DISORDER 152
178 RECTAL HAEMORRHAGE 152
179 ROAD TRAFFIC ACCIDENT 151
180 HOSPITALISATION 150
181 HYPOTENSION 150
182 MUSCULAR WEAKNESS 150
183 PULMONARY EMBOLISM 150
184 COGNITIVE DISORDER 148
185 THINKING ABNORMAL 148
186 INCREASED APPETITE 147
187 AFFECT LABILITY 146
188 CHILLS 146
189 DERMATITIS ATOPIC 145
190 DISCOMFORT 145
191 ABDOMINAL DISTENSION 144
192 GASTROOESOPHAGEAL REFLUX DISEASE 144
193 HYPERSOMNIA 144
194 LOGORRHOEA 142
195 THERAPEUTIC RESPONSE CHANGED 142
196 DEEP VEIN THROMBOSIS 141
197 INFECTION 141
198 AMNESIA 140
199 INITIAL INSOMNIA 140
200 MUSCLE TWITCHING 140
201 DRY SKIN 139
202 DYSPHAGIA 139
203 RAYNAUD^S PHENOMENON 137
204 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 135
205 AUTISM SPECTRUM DISORDER 134
206 SPEECH DISORDER 134
207 CROHN^S DISEASE 133
208 FEAR 133
209 SYSTEMIC LUPUS ERYTHEMATOSUS 133
210 INTENTIONAL DOSE OMISSION 132
211 EXPOSURE DURING PREGNANCY 131
212 FLUSHING 131
213 HOT FLUSH 131
214 PREMATURE DELIVERY 130
215 BRONCHITIS 129
216 PAROSMIA 129
217 PSORIASIS 129
218 DRUG DIVERSION 128
219 NECK PAIN 128
220 CARDIAC MURMUR 127
221 TUBULOINTERSTITIAL NEPHRITIS 124
222 RHINITIS 123
223 BURNS SECOND DEGREE 120
224 GINGIVAL PAIN 120
225 HALLUCINATION, AUDITORY 120
226 RESTLESS LEGS SYNDROME 120
227 DRUG PRESCRIBING ERROR 119
228 FOETAL EXPOSURE DURING PREGNANCY 119
229 PRODUCT DOSE OMISSION 119
230 SWELLING FACE 119
231 HYPOPNOEA 118
232 BRUXISM 117
233 DISTURBANCE IN SOCIAL BEHAVIOUR 116
234 BRONCHIECTASIS 113
235 EUPHORIC MOOD 113
236 FRUSTRATION TOLERANCE DECREASED 113
237 EDUCATIONAL PROBLEM 112
238 GENERAL PHYSICAL HEALTH DETERIORATION 112
239 BLOOD PRESSURE DECREASED 111
240 CATARRH 111
241 POOR QUALITY SLEEP 111
242 STEROID DEPENDENCE 111
243 ALCOHOL POISONING 110
244 BALANCE DISORDER 110
245 JOINT SWELLING 110
246 WRONG TECHNIQUE IN DRUG USAGE PROCESS 110
247 SWELLING 109
248 TREATMENT NONCOMPLIANCE 109
249 OBSESSIVE-COMPULSIVE DISORDER 108
250 PREMATURE BABY 106
251 HALLUCINATION, VISUAL 104
252 PERSONALITY CHANGE 104
253 DEATH 103
254 SKIN EXFOLIATION 103
255 INFLUENZA LIKE ILLNESS 102
256 NEPHROLITHIASIS 102
257 BURNING SENSATION 101
258 EATING DISORDER 101
259 ANOREXIA 100
260 MYDRIASIS 100
261 THERAPY CESSATION 100
262 SKIN DISCOLOURATION 98
263 HEPATIC ENZYME INCREASED 96
264 MENTAL IMPAIRMENT 96
265 RHEUMATOID ARTHRITIS 96
266 EYE PAIN 94
267 EAR INFECTION 92
268 NASAL CONGESTION 92
269 SEROTONIN SYNDROME 92
270 EPISTAXIS 91
271 RHINORRHOEA 91
272 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 90
273 DRY EYE 90
274 PRODUCT STORAGE ERROR 90
275 SOCIAL AVOIDANT BEHAVIOUR 90
276 DISABILITY 89
277 INFUSION RELATED REACTION 89
278 MIDDLE INSOMNIA 89
279 PRODUCT PRESCRIBING ERROR 88
280 PERIPHERAL COLDNESS 87
281 NEGATIVISM 86
282 SOMNAMBULISM 86
283 AFFECTIVE DISORDER 85
284 DISORIENTATION 85
285 DRUG TOLERANCE 85
286 MUSCLE TIGHTNESS 85
287 FLUID RETENTION 84
288 ARRHYTHMIA 83
289 HAEMORRHAGE 83
290 ANAPHYLACTIC REACTION 82
291 CONVULSION 82
292 ERECTILE DYSFUNCTION 81
293 HYPOPHAGIA 81
294 POLLAKIURIA 79
295 PRODUCT TAMPERING 79
296 SKIN BURNING SENSATION 79
297 COMPLETED SUICIDE 78
298 OEDEMA PERIPHERAL 78
299 UNDERDOSE 78
300 INJECTION SITE ERYTHEMA 77
301 INJECTION SITE SWELLING 77
302 INJURY 77
303 PRODUCT DOSE OMISSION IN ERROR 77
304 ACCIDENTAL EXPOSURE TO PRODUCT 75
305 BINGE EATING 75
306 PRODUCT TASTE ABNORMAL 75
307 UPPER RESPIRATORY TRACT INFECTION 75
308 BLOOD CHOLESTEROL INCREASED 74
309 DEVICE BREAKAGE 74
310 DEVICE ISSUE 74
311 EYE IRRITATION 74
312 TARDIVE DYSKINESIA 74
313 DYSPHONIA 73
314 LYMPHADENOPATHY 73
315 POST-TRAUMATIC STRESS DISORDER 73
316 VAGINAL HAEMORRHAGE 73
317 VIRAL INFECTION 73
318 DEVICE EXPULSION 72
319 DRUG EFFECT VARIABLE 72
320 NEURALGIA 72
321 PERFORMANCE STATUS DECREASED 72
322 PSORIATIC ARTHROPATHY 72
323 RETCHING 71
324 SEXUAL DYSFUNCTION 71
325 APHASIA 70
326 ANAEMIA 69
327 INJECTION SITE BRUISING 69
328 MULTIPLE SCLEROSIS 69
329 NEUROPATHY PERIPHERAL 69
330 CELLULITIS 68
331 DELUSION 68
332 GYNAECOMASTIA 68
333 POOR QUALITY PRODUCT ADMINISTERED 68
334 RHESUS INCOMPATIBILITY 68
335 EAR PAIN 67
336 NIGHT SWEATS 67
337 PALLOR 67
338 TACHYPHRENIA 67
339 AMPHETAMINES POSITIVE 66
340 DISEASE RECURRENCE 66
341 HEART RATE DECREASED 66
342 ILL-DEFINED DISORDER 66
343 DRUG SCREEN POSITIVE 65
344 MOBILITY DECREASED 65
345 URINARY RETENTION 65
346 WHEEZING 65
347 AKATHISIA 64
348 APPETITE DISORDER 64
349 DERMATILLOMANIA 64
350 DYSURIA 64
351 FIBROMYALGIA 64
352 MOVEMENT DISORDER 64
353 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 63
354 DRUG DOSE OMISSION BY DEVICE 63
355 DYSARTHRIA 63
356 EXTRA DOSE ADMINISTERED 63
357 HYPOTHYROIDISM 63
358 PRODUCT PACKAGING QUANTITY ISSUE 63
359 ABNORMAL LOSS OF WEIGHT 62
360 DIABETES MELLITUS 62
361 INJECTION SITE REACTION 62
362 LIMB DISCOMFORT 62
363 PAIN IN JAW 62
364 URINARY INCONTINENCE 62
365 THIRST 61
366 ENERGY INCREASED 60
367 IMPAIRED GASTRIC EMPTYING 60
368 ABORTION SPONTANEOUS 59
369 BLISTER 59
370 BLOOD GLUCOSE INCREASED 59
371 ENURESIS 59
372 FLAT AFFECT 59
373 GASTROENTERITIS VIRAL 59
374 COLD SWEAT 58
375 HEAD INJURY 58
376 MYOCARDIAL INFARCTION 58
377 ABNORMAL DREAMS 57
378 FEELING COLD 57
379 IRRITABLE BOWEL SYNDROME 57
380 MULTIPLE SCLEROSIS RELAPSE 57
381 PRESYNCOPE 57
382 SINUS DISORDER 57
383 THERAPY CHANGE 57
384 ANHEDONIA 56
385 CARDIAC ARREST 56
386 CONCUSSION 56
387 HEART RATE IRREGULAR 56
388 MOUTH ULCERATION 56
389 STOMATITIS 56
390 ARTHROPATHY 55
391 COELIAC DISEASE 55
392 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55
393 FEELING OF DESPAIR 55
394 PANIC REACTION 55
395 THROAT IRRITATION 55
396 CARDIAC DISORDER 54
397 MENSTRUATION IRREGULAR 54
398 SENSORY DISTURBANCE 54
399 LIP SWELLING 53
400 PHOTOPHOBIA 53
401 SEASONAL ALLERGY 53
402 SLUGGISHNESS 53
403 ACTIVITIES OF DAILY LIVING IMPAIRED 52
404 AMENORRHOEA 52
405 HEAD DISCOMFORT 52
406 HERPES ZOSTER 52
407 PRODUCT FORMULATION ISSUE 52
408 RESPIRATORY TRACT INFECTION 52
409 ANGIOEDEMA 51
410 DRUG EFFECT INCOMPLETE 51
411 DYSTONIA 51
412 ELECTROCARDIOGRAM QT PROLONGED 51
413 PRODUCT PRESCRIBING ISSUE 51
414 SELF-INJURIOUS IDEATION 51
415 SUICIDAL BEHAVIOUR 51
416 BRAIN INJURY 50
417 EYE SWELLING 50
418 FEELING DRUNK 50
419 INTERVERTEBRAL DISC PROTRUSION 50
420 MAJOR DEPRESSION 50
421 OCULAR HYPERAEMIA 50
422 ALANINE AMINOTRANSFERASE INCREASED 49
423 BEHAVIOUR DISORDER 49
424 DIPLOPIA 49
425 FLATULENCE 49
426 INFLAMMATION 49
427 INJECTION SITE PRURITUS 49
428 LOSS OF EMPLOYMENT 49
429 MUSCULOSKELETAL PAIN 49
430 ORAL HERPES 49
431 PROCEDURAL PAIN 49
432 PRODUCTIVE COUGH 49
433 SKIN DISORDER 49
434 THROMBOSIS 49
435 ACUTE KIDNEY INJURY 48
436 BLOOD PRESSURE ABNORMAL 48
437 EYE DISORDER 48
438 OBESITY 48
439 RASH MACULAR 48
440 RASH PRURITIC 48
441 RENAL FAILURE 48
442 BREECH PRESENTATION 47
443 DRUG WITHDRAWAL SYNDROME NEONATAL 47
444 LIMB INJURY 47
445 SCREAMING 47
446 WHITE BLOOD CELL COUNT DECREASED 47
447 BLINDNESS 46
448 EPILEPSY 46
449 EXPOSURE VIA SKIN CONTACT 46
450 INJECTION SITE HAEMORRHAGE 46
451 PHARYNGITIS STREPTOCOCCAL 46
452 TRICHOTILLOMANIA 46
453 HYPERPHAGIA 45
454 PHARYNGEAL SWELLING 45
455 PREGNANCY 45
456 BODY TEMPERATURE INCREASED 44
457 BONE PAIN 44
458 CAESAREAN SECTION 44
459 DERMATITIS 44
460 HANGOVER 44
461 LIBIDO DECREASED 44
462 LYMPHOCYTE COUNT DECREASED 44
463 PRODUCT DISPENSING ERROR 44
464 QUALITY OF LIFE DECREASED 44
465 CHANGE IN SUSTAINED ATTENTION 43
466 CHRONIC KIDNEY DISEASE 43
467 ECONOMIC PROBLEM 43
468 EXTRAPYRAMIDAL DISORDER 43
469 FUNGAL INFECTION 43
470 HAEMORRHOIDS 43
471 LIVER INJURY 43
472 NARCOLEPSY 43
473 RASH ERYTHEMATOUS 43
474 SUBSTANCE ABUSE 43
475 GROWTH RETARDATION 42
476 NOCTURIA 42
477 PRODUCT USE COMPLAINT 42
478 THROAT TIGHTNESS 42
479 ABDOMINAL PAIN LOWER 41
480 FEEDING DISORDER 41
481 FOOT FRACTURE 41
482 GASTRIC DISORDER 41
483 HYPERACUSIS 41
484 ORAL PAIN 41
485 THERAPY NON-RESPONDER 41
486 APHTHOUS ULCER 40
487 BLOOD POTASSIUM DECREASED 40
488 CATARACT 40
489 FOETAL DISTRESS SYNDROME 40
490 FOOD ALLERGY 40
491 HEAVY MENSTRUAL BLEEDING 40
492 JAUNDICE NEONATAL 40
493 WEIGHT FLUCTUATION 40
494 ANAL INCONTINENCE 39
495 CATAPLEXY 39
496 CHOLELITHIASIS 39
497 DRUG EFFECT DELAYED 39
498 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39
499 NEUROLOGICAL SYMPTOM 39
500 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 39
501 PRODUCT SUPPLY ISSUE 39
502 PSYCHIATRIC SYMPTOM 39
503 SNEEZING 39
504 TRANSFUSION 39
505 HOMICIDAL IDEATION 38
506 INTENTIONAL DRUG MISUSE 38
507 JAUNDICE 38
508 NERVOUS SYSTEM DISORDER 38
509 OSTEOARTHRITIS 38
510 REBOUND EFFECT 38
511 SKIN FISSURES 38
512 TRISMUS 38
513 VITAMIN D DECREASED 38
514 ACCIDENT 37
515 ANKYLOSING SPONDYLITIS 37
516 AUTOIMMUNE DISORDER 37
517 COLITIS 37
518 COMPLICATION OF DEVICE REMOVAL 37
519 DEPRESSED LEVEL OF CONSCIOUSNESS 37
520 EXPOSURE VIA BREAST MILK 37
521 FOOD CRAVING 37
522 HOSTILITY 37
523 IMPAIRED DRIVING ABILITY 37
524 LOCALISED INFECTION 37
525 PANCREATITIS 37
526 PRODUCT ADMINISTRATION ERROR 37
527 SEPSIS 37
528 SNORING 37
529 SOCIAL PROBLEM 37
530 STAPHYLOCOCCAL INFECTION 37
531 SUBSTANCE USE 37
532 ABDOMINAL LYMPHADENOPATHY 36
533 ATRIAL FIBRILLATION 36
534 CHOKING 36
535 COMPLICATION OF DEVICE INSERTION 36
536 DISTRACTIBILITY 36
537 DRUG SCREEN NEGATIVE 36
538 GENERALISED TONIC-CLONIC SEIZURE 36
539 RHABDOMYOLYSIS 36
540 SKIN IRRITATION 36
541 SKIN LESION 36
542 BLOOD GLUCOSE DECREASED 35
543 FORMICATION 35
544 INCORRECT PRODUCT ADMINISTRATION DURATION 35
545 SKIN INFECTION 35
546 TASTE DISORDER 35
547 CARPAL TUNNEL SYNDROME 34
548 COORDINATION ABNORMAL 34
549 DEPRESSIVE SYMPTOM 34
550 DEVICE DISLOCATION 34
551 DYSMENORRHOEA 34
552 DYSPHEMIA 34
553 ERUCTATION 34
554 EXPIRED PRODUCT ADMINISTERED 34
555 EYE PRURITUS 34
556 HYPOMANIA 34
557 OEDEMA 34
558 PRODUCT LABEL ISSUE 34
559 SARS-COV-2 TEST POSITIVE 34
560 SKIN LACERATION 34
561 WEIGHT GAIN POOR 34
562 ANKLE FRACTURE 33
563 DECREASED INTEREST 33
564 DRUG DISPENSING ERROR 33
565 EMOTIONAL POVERTY 33
566 GAIT INABILITY 33
567 GASTRIC ULCER 33
568 GLOSSODYNIA 33
569 HALLUCINATIONS, MIXED 33
570 HEREDITARY ANGIOEDEMA 33
571 JOINT INJURY 33
572 KIDNEY INFECTION 33
573 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 33
574 PULSE ABNORMAL 33
575 BACK DISORDER 32
576 BLOOD PRESSURE FLUCTUATION 32
577 DENTAL CARIES 32
578 HYPERTENSIVE CRISIS 32
579 INFUSION SITE PAIN 32
580 JOINT STIFFNESS 32
581 MUSCLE SPASTICITY 32
582 PRODUCT DISTRIBUTION ISSUE 32
583 SCAR 32
584 SYNOVIAL CYST 32
585 TEARFULNESS 32
586 BRADYCARDIA 31
587 DEVICE MALFUNCTION 31
588 DRUG LEVEL DECREASED 31
589 GASTRITIS 31
590 HYPOAESTHESIA ORAL 31
591 MICTURITION URGENCY 31
592 OCULAR DISCOMFORT 31
593 ORAL DISCOMFORT 31
594 PATHOGEN RESISTANCE 31
595 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31
596 SLEEP-RELATED EATING DISORDER 31
597 TOOTHACHE 31
598 WHITE BLOOD CELL COUNT INCREASED 31
599 ABSCESS 30
600 ASPARTATE AMINOTRANSFERASE INCREASED 30
601 BEDRIDDEN 30
602 BREAST CANCER 30
603 CONTRAINDICATED PRODUCT ADMINISTERED 30
604 DEVICE LEAKAGE 30
605 HYPOKALAEMIA 30
606 INJECTION SITE MASS 30
607 INJECTION SITE RASH 30
608 INJECTION SITE URTICARIA 30
609 INTESTINAL OBSTRUCTION 30
610 NEUTROPENIA 30
611 PAIN OF SKIN 30
612 PELVIC PAIN 30
613 PHARYNGITIS 30
614 PHOTOSENSITIVITY REACTION 30
615 PRODUCT ODOUR ABNORMAL 30
616 TONGUE DISORDER 30
617 DECREASED ACTIVITY 29
618 DEFAECATION URGENCY 29
619 DROOLING 29
620 ENDOMETRIOSIS 29
621 GASTROENTERITIS 29
622 HYPERREFLEXIA 29
623 ONYCHOPHAGIA 29
624 POISONING DELIBERATE 29
625 RENAL IMPAIRMENT 29
626 SELF INJURIOUS BEHAVIOUR 29
627 SINUS TACHYCARDIA 29
628 ADULTERATED PRODUCT 28
629 AMPHETAMINES NEGATIVE 28
630 APPENDICITIS 28
631 BLOOD HIV RNA INCREASED 28
632 CONJUNCTIVITIS 28
633 DEVICE MECHANICAL ISSUE 28
634 DYSSTASIA 28
635 EXECUTIVE DYSFUNCTION 28
636 GALLBLADDER DISORDER 28
637 HAEMOGLOBIN DECREASED 28
638 HEPATIC STEATOSIS 28
639 HYPERTHYROIDISM 28
640 HYPOGLYCAEMIA 28
641 IMPATIENCE 28
642 INAPPROPRIATE AFFECT 28
643 LACRIMATION INCREASED 28
644 NEGATIVE THOUGHTS 28
645 ORTHOSTATIC HYPOTENSION 28
646 SCIATICA 28
647 SLEEP PARALYSIS 28
648 SOMATIC SYMPTOM DISORDER 28
649 UPPER LIMB FRACTURE 28
650 VITAMIN D DEFICIENCY 28
651 ANAL FISSURE 27
652 ANGINA PECTORIS 27
653 BIPOLAR I DISORDER 27
654 BLOOD URINE PRESENT 27
655 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 27
656 CYANOSIS 27
657 CYSTITIS 27
658 DEPENDENCE 27
659 GLAUCOMA 27
660 HEPATIC PAIN 27
661 IMPULSE-CONTROL DISORDER 27
662 MALABSORPTION 27
663 MENSTRUAL DISORDER 27
664 MUSCULOSKELETAL DISCOMFORT 27
665 PRODUCT COMPLAINT 27
666 RENAL DISORDER 27
667 SCRATCH 27
668 SENSATION OF FOREIGN BODY 27
669 SKIN REACTION 27
670 SOCIAL ANXIETY DISORDER 27
671 SUSPECTED PRODUCT TAMPERING 27
672 THEFT 27
673 VIRAL MUTATION IDENTIFIED 27
674 BOWEL MOVEMENT IRREGULARITY 26
675 C-REACTIVE PROTEIN INCREASED 26
676 CHROMATURIA 26
677 CRYPTOSPORIDIOSIS INFECTION 26
678 DERMATITIS CONTACT 26
679 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 26
680 DRUG ADMINISTRATION ERROR 26
681 DRUG TITRATION ERROR 26
682 HORMONE LEVEL ABNORMAL 26
683 HYSTERECTOMY 26
684 LOWER LIMB FRACTURE 26
685 LOWER RESPIRATORY TRACT INFECTION 26
686 MENORRHAGIA 26
687 MENSTRUATION DELAYED 26
688 OBSESSIVE THOUGHTS 26
689 PARALYSIS 26
690 UNRESPONSIVE TO STIMULI 26
691 BLOOD CREATININE INCREASED 25
692 CLOSTRIDIUM DIFFICILE INFECTION 25
693 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25
694 EYE MOVEMENT DISORDER 25
695 HEART RATE ABNORMAL 25
696 JOB DISSATISFACTION 25
697 LIBIDO INCREASED 25
698 LIGAMENT SPRAIN 25
699 LIVER DISORDER 25
700 MENTAL STATUS CHANGES 25
701 NEEDLE ISSUE 25
702 NEUTROPHIL COUNT INCREASED 25
703 PARAESTHESIA ORAL 25
704 PLATELET COUNT INCREASED 25
705 PRODUCT COLOUR ISSUE 25
706 SCHIZOPHRENIA 25
707 TENSION 25
708 TOOTH DISORDER 25
709 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 25
710 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 24
711 AGEUSIA 24
712 BLADDER DISORDER 24
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 24
714 CANDIDA INFECTION 24
715 CEREBRAL DISORDER 24
716 CRANIOCEREBRAL INJURY 24
717 DISORGANISED SPEECH 24
718 EAR DISCOMFORT 24
719 FEBRILE NEUTROPENIA 24
720 HYPOACUSIS 24
721 IMPAIRED HEALING 24
722 INCORRECT DOSE ADMINISTERED BY DEVICE 24
723 LEUKOPENIA 24
724 MALNUTRITION 24
725 NERVE COMPRESSION 24
726 NERVE INJURY 24
727 POISONING 24
728 PRODUCT PHYSICAL CONSISTENCY ISSUE 24
729 PRODUCT PREPARATION ERROR 24
730 TERMINAL INSOMNIA 24
731 ULCER 24
732 VENTRICULAR EXTRASYSTOLES 24
733 WOUND 24
734 ALCOHOLISM 23
735 APNOEA 23
736 BLOOD IRON DECREASED 23
737 CLAUSTROPHOBIA 23
738 FEELING OF BODY TEMPERATURE CHANGE 23
739 FOREIGN BODY IN REPRODUCTIVE TRACT 23
740 GAMBLING DISORDER 23
741 HAEMATEMESIS 23
742 IMMUNODEFICIENCY 23
743 INCOHERENT 23
744 MAST CELL ACTIVATION SYNDROME 23
745 OVERWEIGHT 23
746 PARANASAL SINUS DISCOMFORT 23
747 PHARYNGEAL OEDEMA 23
748 POOR VENOUS ACCESS 23
749 PSYCHOTIC BEHAVIOUR 23
750 RASH GENERALISED 23
751 SKIN ABRASION 23
752 SKIN HAEMORRHAGE 23
753 SPINAL OPERATION 23
754 STEVENS-JOHNSON SYNDROME 23
755 SUSPECTED COUNTERFEIT PRODUCT 23
756 THERAPEUTIC PRODUCT EFFECT DELAYED 23
757 TOOTH FRACTURE 23
758 CARDIAC FAILURE 22
759 CLUMSINESS 22
760 COMPULSIONS 22
761 DISEASE PROGRESSION 22
762 ELECTRIC SHOCK SENSATION 22
763 FRUSTRATION 22
764 HAEMATOCRIT DECREASED 22
765 HERNIA 22
766 HYPERSEXUALITY 22
767 HYPERVENTILATION 22
768 INTERVERTEBRAL DISC DEGENERATION 22
769 JAW DISORDER 22
770 KNEE ARTHROPLASTY 22
771 LIP DRY 22
772 METABOLIC DISORDER 22
773 NEAR DEATH EXPERIENCE 22
774 NEOPLASM MALIGNANT 22
775 NONSPECIFIC REACTION 22
776 OSTEOPOROSIS 22
777 OVARIAN CYST 22
778 OXYGEN SATURATION DECREASED 22
779 RASH PAPULAR 22
780 RESPIRATORY ARREST 22
781 SLEEP TERROR 22
782 THERAPEUTIC REACTION TIME DECREASED 22
783 TOURETTE^S DISORDER 22
784 WRIST FRACTURE 22
785 YAWNING 22
786 ALCOHOL USE 21
787 ANTISOCIAL BEHAVIOUR 21
788 BLEPHAROSPASM 21
789 CARDIOVASCULAR DISORDER 21
790 CHOLECYSTECTOMY 21
791 COMPLICATION ASSOCIATED WITH DEVICE 21
792 DEAFNESS 21
793 DIVERTICULITIS 21
794 FISTULA 21
795 FOOD POISONING 21
796 GASTROINTESTINAL PAIN 21
797 GLUCOSE TOLERANCE IMPAIRED 21
798 HYPERMETABOLISM 21
799 METRORRHAGIA 21
800 MULTIPLE ALLERGIES 21
801 SEIZURE LIKE PHENOMENA 21
802 SINUS CONGESTION 21
803 SKIN ULCER 21
804 SLEEP DEFICIT 21
805 TACHYPNOEA 21
806 TEMPERATURE INTOLERANCE 21
807 THYROID DISORDER 21
808 TONGUE DISCOMFORT 21
809 TRANSIENT ISCHAEMIC ATTACK 21
810 TYPE 2 DIABETES MELLITUS 21
811 UNDERWEIGHT 21
812 URINE AMPHETAMINE POSITIVE 21
813 UVEITIS 21
814 ACNE CYSTIC 20
815 ANXIETY DISORDER 20
816 BACK INJURY 20
817 BLOOD PRESSURE SYSTOLIC INCREASED 20
818 DELIRIUM 20
819 DRUG-INDUCED LIVER INJURY 20
820 DYSPNOEA EXERTIONAL 20
821 EMBEDDED DEVICE 20
822 ENCEPHALOPATHY 20
823 GOUT 20
824 HYPOXIA 20
825 LYME DISEASE 20
826 MOUTH SWELLING 20
827 ORAL CANDIDIASIS 20
828 OSTEOPENIA 20
829 PLATELET COUNT DECREASED 20
830 PRODUCT ADHESION ISSUE 20
831 PRODUCT SOLUBILITY ABNORMAL 20
832 PULMONARY OEDEMA 20
833 RESPIRATORY RATE INCREASED 20
834 RIB FRACTURE 20
835 STRESS CARDIOMYOPATHY 20
836 TOOTH INFECTION 20
837 UPPER-AIRWAY COUGH SYNDROME 20
838 UTERINE LEIOMYOMA 20
839 VIOLENCE-RELATED SYMPTOM 20
840 VISUAL ACUITY REDUCED 20
841 ABASIA 19
842 ALTERED STATE OF CONSCIOUSNESS 19
843 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19
844 DEPERSONALISATION/DEREALISATION DISORDER 19
845 DEVICE INFORMATION OUTPUT ISSUE 19
846 DEVICE USE ISSUE 19
847 FOOT DEFORMITY 19
848 HAIR GROWTH ABNORMAL 19
849 HEPATIC ENZYME ABNORMAL 19
850 HEPATITIS VIRAL 19
851 HYPERAESTHESIA 19
852 JAW CLICKING 19
853 NASAL SEPTUM DEVIATION 19
854 POOR PERIPHERAL CIRCULATION 19
855 RESPIRATION ABNORMAL 19
856 RESPIRATORY FAILURE 19
857 SUSPECTED PRODUCT QUALITY ISSUE 19
858 TEMPOROMANDIBULAR JOINT SYNDROME 19
859 ANAL FISTULA 18
860 APHONIA 18
861 BLOOD BILIRUBIN INCREASED 18
862 BLOOD THYROID STIMULATING HORMONE INCREASED 18
863 BLOOD TRIGLYCERIDES INCREASED 18
864 DIZZINESS POSTURAL 18
865 EOSINOPHIL COUNT INCREASED 18
866 HAEMATOMA 18
867 HEPATITIS 18
868 LUNG DISORDER 18
869 MENOPAUSE 18
870 MUSCLE RIGIDITY 18
871 OBSTRUCTIVE SLEEP APNOEA SYNDROME 18
872 OPPOSITIONAL DEFIANT DISORDER 18
873 PHYSICAL ASSAULT 18
874 PRODUCT PREPARATION ISSUE 18
875 SELF-DESTRUCTIVE BEHAVIOUR 18
876 SJOGREN^S SYNDROME 18
877 STARING 18
878 STATUS EPILEPTICUS 18
879 TINEA PEDIS 18
880 VISUAL FIELD DEFECT 18
881 VITAMIN B12 DEFICIENCY 18
882 ALCOHOL ABUSE 17
883 ANORGASMIA 17
884 ARTHROPOD BITE 17
885 BLOOD PRESSURE DIASTOLIC INCREASED 17
886 BLOOD SODIUM DECREASED 17
887 BLOOD TESTOSTERONE DECREASED 17
888 COMPULSIVE SHOPPING 17
889 CONDUCT DISORDER 17
890 DYSPHORIA 17
891 FACIAL PARALYSIS 17
892 FALLOT^S TETRALOGY 17
893 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17
894 HIDRADENITIS 17
895 INCORRECT DOSAGE ADMINISTERED 17
896 INFUSION SITE ERYTHEMA 17
897 INFUSION SITE SWELLING 17
898 INTRUSIVE THOUGHTS 17
899 KNEE OPERATION 17
900 MOTOR DYSFUNCTION 17
901 MUCOUS STOOLS 17
902 MUSCLE STRAIN 17
903 MUSCULOSKELETAL CHEST PAIN 17
904 OPTIC NEURITIS 17
905 PANCREATITIS ACUTE 17
906 PERSONALITY DISORDER 17
907 PROCTALGIA 17
908 PRODUCT TEMPERATURE EXCURSION ISSUE 17
909 SCAB 17
910 SUPRAVENTRICULAR TACHYCARDIA 17
911 TENDONITIS 17
912 VAGINAL DISCHARGE 17
913 ABNORMAL WEIGHT GAIN 16
914 ADVERSE REACTION 16
915 ANAPHYLACTIC SHOCK 16
916 ASPIRATION 16
917 BLOOD PROLACTIN INCREASED 16
918 COMA 16
919 DEVICE DIFFICULT TO USE 16
920 FOOD INTERACTION 16
921 GALACTORRHOEA 16
922 GENERALISED ANXIETY DISORDER 16
923 GLYCOSYLATED HAEMOGLOBIN INCREASED 16
924 HIATUS HERNIA 16
925 HYPONATRAEMIA 16
926 INFUSION SITE PRURITUS 16
927 LABORATORY TEST ABNORMAL 16
928 LIVER FUNCTION TEST ABNORMAL 16
929 LIVER FUNCTION TEST INCREASED 16
930 MENISCUS INJURY 16
931 MYOCARDITIS 16
932 NICOTINE DEPENDENCE 16
933 ORAL MUCOSAL BLISTERING 16
934 PANIC DISORDER 16
935 PERIPHERAL VASCULAR DISORDER 16
936 POLYDIPSIA 16
937 SINUS PAIN 16
938 SKIN ODOUR ABNORMAL 16
939 SPINAL DISORDER 16
940 STREPTOCOCCAL INFECTION 16
941 SYMPTOM RECURRENCE 16
942 THROMBOCYTOPENIA 16
943 URINE ABNORMALITY 16
944 VITREOUS FLOATERS 16
945 ABNORMAL SLEEP-RELATED EVENT 15
946 APPLICATION SITE ERYTHEMA 15
947 APPLICATION SITE PAIN 15
948 BACTERIAL INFECTION 15
949 BLOOD GLUCOSE ABNORMAL 15
950 BREAST PAIN 15
951 BREAST TENDERNESS 15
952 CARDIOMYOPATHY 15
953 CEREBRAL HAEMORRHAGE 15
954 CYST 15
955 DAYDREAMING 15
956 DEAFNESS UNILATERAL 15
957 DEREALISATION 15
958 DRUG SCREEN FALSE POSITIVE 15
959 ELECTROCARDIOGRAM ABNORMAL 15
960 EXCESSIVE EYE BLINKING 15
961 FAECES DISCOLOURED 15
962 GRAND MAL CONVULSION 15
963 INCORRECT PRODUCT STORAGE 15
964 INJECTION SITE INDURATION 15
965 INTENTIONAL UNDERDOSE 15
966 LACTIC ACIDOSIS 15
967 LOSS OF LIBIDO 15
968 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 15
969 MUSCULOSKELETAL DISORDER 15
970 OESOPHAGITIS 15
971 ORAL ADMINISTRATION COMPLICATION 15
972 PATIENT DISSATISFACTION WITH TREATMENT 15
973 PENIS INJURY 15
974 PREMENSTRUAL DYSPHORIC DISORDER 15
975 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15
976 PRURITUS GENERALISED 15
977 RESPIRATORY DISORDER 15
978 SELF ESTEEM DECREASED 15
979 SKIN SWELLING 15
980 SPINAL PAIN 15
981 SPUTUM DISCOLOURED 15
982 STRESS AT WORK 15
983 TENSION HEADACHE 15
984 TONGUE ULCERATION 15
985 TOOTH ABSCESS 15
986 TOOTH LOSS 15
987 TYPE 1 DIABETES MELLITUS 15
988 VASCULITIS 15
989 VIRAL UPPER RESPIRATORY TRACT INFECTION 15
990 ADRENAL INSUFFICIENCY 14
991 ANGIOPATHY 14
992 AUTOIMMUNE THYROIDITIS 14
993 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14
994 BRAIN OEDEMA 14
995 BREAST MASS 14
996 CARDIAC FAILURE ACUTE 14
997 CARDIAC FAILURE CONGESTIVE 14
998 COMPULSIVE HOARDING 14
999 DEFIANT BEHAVIOUR 14